Characterization of Kawasaki’s disease in four private hospitals from Guatemala
Article Details
Authors
Publication Information
Keywords
Kawasaki syndrome
Mucocutaneous Lymph Node Syndrome
Abstract
Background: Kawasaki disease is an acute systemic vasculitis which mainly involves medium caliber arteries and has become the first cause of acquired heart disease in children. Its frequency is greater in children < 5 years. There is no known etiologic agent. It has not been described previously in Guatemala.
Objective: Determine the clinical presentation, diagnosis, treatment, and results of the charts of children from 0 to 12 years of age diagnosed with Kawasaki disease. Design: Descriptive, cross-sectional study, realized in private hospitals in Guatemala City. Results: During the period of January 2003 and December 2013, 26 cases of Kawasaki disease where identified in the study group. All cases except 1 were in children under 5 years of age. All patients had a history of fever even though only 11 presented fever upon entering the hospital. More than 75% of patients had rash, red eyes without discharge, changes in oropharynx and changes in extremities. All patients received immunoglobulin and aspirin in their treatment. 7 received steroids. 15 were Complete Kawasaki, 7 Incomplete Kawasaki, and 4 were diagnosed with Kawasaki disease but not according to guidelines. Limitations: Deficiency in the medical and paramedical teams to fill out correctly a medical chart. Difficulty in gathering data from archives, especially from old files. Conclusions: The description of the disease resembles that in the literature and it is present in the population of the country. The disease was diagnosed and treated correctly.
Graph - Number of readers per month
Downloads
How to Cite
License
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
Copyright notice |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. | |
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. | |
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
About the Creative Commons license |
Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
You are free to: |
Share — copy and redistribute the material in any medium or format. | |
Adapt — remix, transform, and build upon the material. | |
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. | |
NonCommercial — You may not use the material for commercial purposes. | |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
|
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |